(Q73234433)
Statements
Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to Reduce IDDM in the Genetically at Risk (English)
Hämäläinen AM
Ronkainen MS
Akerblom HK